Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression

<p>Supplementary Table S2: Sample Summary. List of patients and samples (timepoints) included in the current study.</p>

保存先:
書誌詳細
第一著者: Stephanie Lheureux (16797697) (author)
その他の著者: Stephenie D. Prokopec (16797700) (author), Leslie E. Oldfield (16797703) (author), Eduardo Gonzalez-Ochoa (16375918) (author), Jeffrey P. Bruce (16797706) (author), Derek Wong (15135437) (author), Arnavaz Danesh (15135449) (author), Dax Torti (15135467) (author), Jonathan Torchia (16797709) (author), Alexander Fortuna (16797712) (author), Sharanjit Singh (16797715) (author), Matthew Irving (16797718) (author), Kayla Marsh (15135470) (author), Bernard Lam (15051558) (author), Vanessa Speers (16797721) (author), Aleksandra Yosifova (16797724) (author), Ana Oaknin (14956029) (author), Ainhoa Madariaga (15129719) (author), Neesha C. Dhani (16797727) (author), Valerie Bowering (16797730) (author), Amit M. Oza (15129737) (author), Trevor J. Pugh (14940894) (author)
出版事項: 2025
主題:
Cancer
Methods and Technology
Computational Methods
Sequence analysis
Gynecological Cancers
Ovarian cancer
Liquid Biopsy
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
その他の書誌記述
要約:<p>Supplementary Table S2: Sample Summary. List of patients and samples (timepoints) included in the current study.</p>

類似資料